Xerostomia
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 programRemineralizing Extreme Dry Mouth Spray with XylitolN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CamurusXER2020
Jerusalem PharmaceuticalsElectrostimulation
Johnson & JohnsonRemineralizing Extreme Dry Mouth Spray with Xylitol
Clinical Trials (3)
Total enrollment: 329 patients across 3 trials
Effects of Mucoprotective Product on Xerostomia
Start: Feb 2011Est. completion: Jun 2011
Phase 4Completed
Evaluation of an Electro-stimulator for the Treatment of Xerostomia
Start: Jan 2007Est. completion: Apr 2010200 patients
Phase 4Completed
Blinded Dry Mouth Spray Crossover Study
Start: Jan 2021Est. completion: Jun 2023129 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space